NCT02836535

Brief Summary

The purpose of this study is to understand the patient experience with an adverse event after surgery. An adverse event is an undesirable experience or complication associated with your surgery.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
9

participants targeted

Target at below P25 for all trials

Timeline
Completed

Started Jul 2016

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

July 1, 2016

Completed
12 days until next milestone

First Submitted

Initial submission to the registry

July 13, 2016

Completed
6 days until next milestone

First Posted

Study publicly available on registry

July 19, 2016

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 28, 2017

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 28, 2017

Completed
Last Updated

June 29, 2017

Status Verified

August 1, 2016

Enrollment Period

12 months

First QC Date

July 13, 2016

Last Update Submit

June 28, 2017

Conditions

Keywords

complicationssurgery

Outcome Measures

Primary Outcomes (1)

  • Number of complications

    Information gathered from these interviews will form the basis for the conceptual model of surgical complications. Qualitative data will be obtained from patients who have directly experienced a surgical complication. These complications are defined and categorized by the Common Terminology Criteria for Adverse Events (CTCAE) version 4.0.

    within 90 days

Study Arms (2)

patients with complications

Each subject will participate in an audio-recorded interview, either in-person or by telephone, expected to last 30 to 60 minutes. Subjects' responses to the interview questions and basic demographic data will remain confidential. The interview will examine the impact of complications utilizing a semi-structured script specific to each group

Behavioral: qualitative interviews

patients without Complications (control group)

Each subject will participate in an audio-recorded interview, either in-person or by telephone, expected to last 30 to 60 minutes. Subjects' responses to the interview questions and basic demographic data will remain confidential.

Behavioral: qualitative interviews

Interventions

patients with complicationspatients without Complications (control group)

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients at MSK

You may qualify if:

  • Age 18 or older
  • Patients who had elective surgery for a primary colorectal cancer within the last 90 days.
  • Patients who either:
  • Develop an eligible complication (Appendix 1) within 30 days of surgery (n = 25 - 30)
  • Do not develop any complication after surgery (n = 25 - 30)

You may not qualify if:

  • Multivisceral resections
  • Metastatic or locally-recurrent disease
  • Physical impairment that may prevent participation in an interview or survey setting
  • Active psychiatric illness, cognitive or sensory impairment
  • Inability to speak or understand English
  • Refusal to participate in an audio-recorded interview
  • Inability to participate in an audio-recorded interview for reasons not otherwise specified
  • Any second surgical procedure unrelated to the complication within the 90-day period

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Memorial Sloan Kettering Cancer Center

New York, New York, 10065, United States

Location

Related Links

MeSH Terms

Conditions

Colorectal Neoplasms

Condition Hierarchy (Ancestors)

Intestinal NeoplasmsGastrointestinal NeoplasmsDigestive System NeoplasmsNeoplasms by SiteNeoplasmsDigestive System DiseasesGastrointestinal DiseasesColonic DiseasesIntestinal DiseasesRectal Diseases

Study Officials

  • Larissa Temple, MD, MSc

    Memorial Sloan Kettering Cancer Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

July 13, 2016

First Posted

July 19, 2016

Study Start

July 1, 2016

Primary Completion

June 28, 2017

Study Completion

June 28, 2017

Last Updated

June 29, 2017

Record last verified: 2016-08

Locations